| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 16786393
[patent_doc_number] => 10988808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Synthesizing barcoding sequences utilizing phase-shift blocks and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/802264
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12987
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/802264 | Synthesizing barcoding sequences utilizing phase-shift blocks and uses thereof | Feb 25, 2020 | Issued |
Array
(
[id] => 16523675
[patent_doc_number] => 20200397755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 16/799556
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799556 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Feb 23, 2020 | Abandoned |
Array
(
[id] => 17670914
[patent_doc_number] => 20220184081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => ANTIPRURITIC AGENT USING PAC1 RECEPTOR ANTAGONIST
[patent_app_type] => utility
[patent_app_number] => 17/430557
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430557 | ANTIPRURITIC AGENT USING PAC1 RECEPTOR ANTAGONIST | Feb 11, 2020 | Pending |
Array
(
[id] => 17149440
[patent_doc_number] => 11142502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/779796
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 36
[patent_no_of_words] => 17988
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16779796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/779796 | (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof | Feb 2, 2020 | Issued |
Array
(
[id] => 16743473
[patent_doc_number] => 10968448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Methods and compositions using one-sided transposition
[patent_app_type] => utility
[patent_app_number] => 16/736043
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18668
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736043 | Methods and compositions using one-sided transposition | Jan 6, 2020 | Issued |
Array
(
[id] => 15869093
[patent_doc_number] => 20200141950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/736442
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736442
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736442 | DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS | Jan 6, 2020 | Abandoned |
Array
(
[id] => 16970401
[patent_doc_number] => 11066361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
[patent_app_type] => utility
[patent_app_number] => 16/732537
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 42498
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732537 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Jan 1, 2020 | Issued |
Array
(
[id] => 18315097
[patent_doc_number] => 11629166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Compound for treating clostridium difficile
[patent_app_type] => utility
[patent_app_number] => 16/725890
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28914
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725890
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725890 | Compound for treating clostridium difficile | Dec 22, 2019 | Issued |
Array
(
[id] => 16157239
[patent_doc_number] => 20200216852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Method for Producing Recombinant 11-De-O-Methyltomaymycin
[patent_app_type] => utility
[patent_app_number] => 16/720885
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720885 | Method for Producing Recombinant 11-De-O-Methyltomaymycin | Dec 18, 2019 | Abandoned |
Array
(
[id] => 16361348
[patent_doc_number] => 20200318099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => POLYPEPTIDE DISPLAY LIBRARIES AND METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/710909
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710909 | Polypeptide display libraries and methods of making and using thereof | Dec 10, 2019 | Issued |
Array
(
[id] => 16861672
[patent_doc_number] => 11020394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-a4b7 integrin blocking antibodies
[patent_app_type] => utility
[patent_app_number] => 16/708167
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 15466
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708167 | Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-a4b7 integrin blocking antibodies | Dec 8, 2019 | Issued |
Array
(
[id] => 17015157
[patent_doc_number] => 11084783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins
[patent_app_type] => utility
[patent_app_number] => 16/700327
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 26227
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700327 | O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins | Dec 1, 2019 | Issued |
Array
(
[id] => 17385483
[patent_doc_number] => 20220033335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON
[patent_app_type] => utility
[patent_app_number] => 17/297170
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297170 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | Nov 25, 2019 | Abandoned |
Array
(
[id] => 17680015
[patent_doc_number] => 11364246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 16/501493
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 77491
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 417
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16501493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/501493 | Compounds | Nov 21, 2019 | Issued |
Array
(
[id] => 15527855
[patent_doc_number] => 20200056233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => METHODS OF PREPARING AND ANALYZING CELL-FREE NUCLEIC ACID SEQUENCING LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 16/663147
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16663147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/663147 | Methods of preparing and analyzing cell-free nucleic acid sequencing libraries | Oct 23, 2019 | Issued |
Array
(
[id] => 17258394
[patent_doc_number] => 20210371379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => NOVEL SALT OF 4-({(4S)-1-(4-CARBAMIMIDOYLBENZOYL)-4-[4(METHYLSULFONYL)PIPERAZIN-1-YL]-L-PROLYL}AMINO) BENZOIC ACID AND NOVEL CRYSTAL FORM THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/277983
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277983 | NOVEL SALT OF 4-({(4S)-1-(4-CARBAMIMIDOYLBENZOYL)-4-[4(METHYLSULFONYL)PIPERAZIN-1-YL]-L-PROLYL}AMINO) BENZOIC ACID AND NOVEL CRYSTAL FORM THEREOF | Sep 18, 2019 | Abandoned |
Array
(
[id] => 15650255
[patent_doc_number] => 20200087657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => HIGH-THROUGHPUT IDENTIFICATON OF INTERMOLECULAR INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/575124
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575124 | High-throughput identification of intermolecular interactions | Sep 17, 2019 | Issued |
Array
(
[id] => 17274415
[patent_doc_number] => 20210380613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/276899
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276899 | METHODS FOR PREPARING ARYLPHOSPHINE-BORANE COMPLEXES | Sep 17, 2019 | Abandoned |
Array
(
[id] => 15802951
[patent_doc_number] => 20200124618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => COMBINATORIAL SYNTHESIS AND BIOMARKER DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 16/572424
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572424 | COMBINATORIAL SYNTHESIS AND BIOMARKER DEVELOPMENT | Sep 15, 2019 | Abandoned |
Array
(
[id] => 16564492
[patent_doc_number] => 10889853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => RNA microarray for detecting interaction between protein and RNA containing a higher-order structure
[patent_app_type] => utility
[patent_app_number] => 16/562470
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 11002
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562470
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562470 | RNA microarray for detecting interaction between protein and RNA containing a higher-order structure | Sep 5, 2019 | Issued |